Novel modified released formulation

Details for Australian Patent Application No. 2002228579 (hide)

Owner AstraZeneca AB

Inventors Juppo, Anne

Agent Davies Collison Cave

Pub. Number AU-B-2002228579

PCT Pub. Number WO2002/064121

Priority 0100477-9 13.02.01 SE; 0100478-7 13.02.01 SE

Filing date 8 February 2002

Wipo publication date 28 August 2002

Acceptance publication date 27 July 2006

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/52 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002228579

27 July 2006 Application Accepted

  Published as AU-B-2002228579

23 November 2006 Standard Patent Sealed

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228580-METHOD AND SYSTEM OF THROUGHPUT CONTROL OF SHARED CHANNELS

2002228578-METHOD AND DEVICE FOR RECOGNITION OF A HANDWRITTEN PATTERN